Diabetes gene therapy
Latest Information Update: 19 Jul 2002
At a glance
- Originator Nonindustrial source; Pfizer
- Class Diabetes gene therapies
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Diabetes mellitus